Table 3 EVIDEM heat score by dimension
Criteria | Mean | Standard Deviation | Low 95% CL Mean | Upper 95% CL Mean | 25th Percentile | 75th Percentile |
|---|---|---|---|---|---|---|
Disease severity | 87.2 | 17.3 | 50.0 | 100.0 | 75.0 | 100.0 |
Size of affected population | 88.5 | 16.2 | 50.0 | 100.0 | 75.0 | 100.0 |
Unmet needs | 95.9 | 12.5 | 50.0 | 100.0 | 100.0 | 100.0 |
Comparative effectiveness | 99.5 | 2.7 | 83.3 | 100.0 | 100.0 | 100.0 |
Comparative safety/tolerability | 92.8 | 14.5 | 50.0 | 100.0 | 100.0 | 100.0 |
Comparative patient-perceived health / PRO | 51.7 | 21.9 | 12.5 | 100.0 | 37.5 | 62.5 |
Type of preventive benefit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Type of therapeutic benefit | 94.6 | 15.7 | 50.0 | 100.0 | 100.0 | 100.0 |
Comparative– cost of intervention | 74.3 | 32.5 | 0.0 | 100.0 | 50.0 | 100.0 |
Comparative – other medical costs | 74.3 | 32.5 | 0.0 | 100.0 | 50.0 | 100.0 |
Comparative – non-medical costs | 6.8 | 5.3 | 0.0 | 20.0 | 0.0 | 10.0 |
Quality of evidence | 64.0 | 23.4 | 22.2 | 100.0 | 44.4 | 83.3 |
Expert consensus/clinical practice guidelines | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Contextual criteria | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Mandate and scope of the healthcare system | 51.1 | 13.9 | 30.0 | 60.0 | 30.0 | 60.0 |
Population priorities and access | 23.5 | 14.4 | 0.0 | 60.0 | 30.0 | 30.0 |
Common goal and specific interests | 7.8 | 5.8 | 0.0 | 20.0 | 0.0 | 10.0 |
Environmental impact | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
System capacity & appropriate use of intervention | 25.9 | 16.3 | 0.0 | 53.3 | 13.3 | 40.0 |
Political/historical/cultural context | 19.5 | 17.6 | 0.0 | 60.0 | 0.0 | 30.0 |
GLOBAL | 47.9 | 5.8 | 31.2 | 60.5 | 44.7 | 51.25 |